Skip to main content

Want a detailed portfolio tracker?

Titan Pharmaceuticals Inc (de) (TTNP) Profit Margin (2016 - 2023)

Titan Pharmaceuticals Inc (de) (TTNP) profit margin from Jun 30, 2016 to Jun 30, 2023. The current Titan Pharmaceuticals Inc (de) (TTNP) profit margin is -1987.50%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Titan Pharmaceuticals Inc (de) (TTNP)

YearProfit MarginChange
2023-3094.44%
+69.72%
2022-1823.21%
+217.71%
2021-573.86%
+52.27%
2020-376.86%
-40.24%
2019-630.65%
+362.85%
2018-136.25%
-97.91%
2017-6504.55%
-19170.72%
201634.11%
-105.05%
2015-675.45%
N/A

Comparison Titan Pharmaceuticals Inc (de) (TTNP) profit margin with competitors

Titan Pharmaceuticals Inc (de) (TTNP) profit margin is -1987.50%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-143.82%
PRTCPureTech Health plc American Depositary Shares793.00%-139.90%
ABEOAbeona Therapeutics Inc454.90%-122.89%
CHRSCoherus Biosciences Inc397.30%-119.99%
FBIOFortress Biotech Inc193.10%-109.72%
INVAInnoviva Inc119.90%-106.03%
ZVRAZevra Therapeutics Inc101.60%-105.11%
ABUSArbutus Biopharma Corp94.73%-104.77%
SAVACassava Sciences Inc.93.68%-104.71%
GLPGGalapagos NV86.83%-104.37%
CTNMContineum Therapeutics Inc - Class A83.13%-104.18%
BDTXBlack Diamond Therapeutics Inc80.77%-104.06%
NEUPNeuphoria Therapeutics Inc75.08%-103.78%
IPSCCentury Therapeutics Inc70.13%-103.53%
FULCFulcrum Therapeutics Inc69.26%-103.48%
CVACCureVac N.V.68.44%-103.44%
PRTAProthena Corporation plc64.05%-103.22%
QTTBQ32 Bio Inc61.90%-103.11%
AVIRAtea Pharmaceuticals Inc60.95%-103.07%
ASNDAscendis Pharma A/S57.30%-102.88%
PLXProtalix BioTherapeutics Inc54.27%-102.73%
HCWBHCW Biologics Inc53.42%-102.69%
AGENAgenus Inc52.20%-102.63%
CGENCompugen Ltd48.57%-102.44%
KRYSKrystal Biotech Inc48.07%-102.42%
RPRXRoyalty Pharma plc - Class A46.73%-102.35%
XOMAPXOMA Royalty Corp45.90%-102.31%
XOMAOXOMA Royalty Corp45.90%-102.31%
AUPHAurinia Pharmaceuticals Inc44.21%-102.22%
NXTCNextcure Inc43.49%-102.19%
CPRXCatalyst Pharmaceuticals Inc42.66%-102.15%
HALOHalozyme Therapeutics Inc39.83%-102.00%
ADMAAdma Biologics Inc39.59%-101.99%
XOMAXOMA Royalty Corp36.25%-101.82%
VRTXVertex Pharmaceuticals Inc34.53%-101.74%
EXELExelixis Inc34.46%-101.73%
SLNOSoleno Therapeutics Inc33.17%-101.67%
CRMDCorMedix Inc30.29%-101.52%
TNGXTango Therapeutics Inc29.52%-101.49%
ARGXArgen X SE28.20%-101.42%
CAICaris Life Sciences Inc - Class A27.98%-101.41%
JAZZJazz Pharmaceuticals plc27.42%-101.38%
SPROSpero Therapeutics Inc24.90%-101.25%
INCYIncyte Corp23.83%-101.20%
REGNRegeneron Pharmaceuticals Inc20.17%-101.01%
NAGENiagen Bioscience Inc20.07%-101.01%
ICCCImmucell Corp18.75%-100.94%
NERVMinerva Neurosciences Inc17.79%-100.90%
ALNYAlnylam Pharmaceuticals Inc16.99%-100.85%
ENVBEnveric Biosciences Inc16.64%-100.84%
TECHBio-Techne Corp16.39%-100.82%
HRMYHarmony Biosciences Holdings Inc15.08%-100.76%
ONCBeiGene Ltd15.02%-100.76%
RIGLRigel Pharmaceuticals14.71%-100.74%
BMRNBiomarin Pharmaceutical Inc13.77%-100.69%
VXRTVaxart Inc13.20%-100.66%
IMCRImmunocore Holdings plc12.16%-100.61%
VRNAVerona Pharma Plc11.56%-100.58%
TGTXTG Therapeutics Inc9.65%-100.49%
APLSApellis Pharmaceuticals Inc6.95%-100.35%
PTGXProtagonist Therapeutics Inc6.71%-100.34%
NUVBNuvation Bio Inc - Class A6.48%-100.33%
FBIOPFortress Biotech Inc6.40%-100.32%
GMABGenmab5.92%-100.30%
SRPTSarepta Therapeutics Inc2.98%-100.15%
BMEABiomea Fusion Inc2.37%-100.12%
ACADAcadia Pharmaceuticals Inc1.36%-100.07%
FENCFennec Pharmaceuticals Inc1.33%-100.07%
FOLDAmicus Therapeutics Inc0.91%-100.05%
HOTHHoth Therapeutics Inc0.17%-100.01%
BBLGBone Biologics Corp0.02%-100.00%